GlassScriptPhysician profile
Stephanie W Belokin
NPI 1134481849
$521.12
in general payments reported to CMS, 2019-2025
13 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $77.33 · 2022: $60.74 · 2023: $101 · 2024: $77.20 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $121.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $62.95 | 2019-2024 | Mounjaro, Zepbound |
| Abbott Laboratories | $57.82 | 2022-2023 | Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $55.28 | 2024-2025 | Airsupra, Breztri |
| Sumitomo Pharma America, INC. | $47.79 | 2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.31 | 2019-2020 | |
| Pfizer INC. | $32.72 | 2020-2022 | |
| Glaxosmithkline, LLC. | $30.15 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.66 | 2019 | |
| Amarin Pharma, INC. | $15.87 | 2020 | |
| Amgen INC. | $15.75 | 2019 | |
| Exact Sciences Corporation | $14.52 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Belokin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.